Related Experiment Video
Updated: May 11, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Rotavirus vaccination in central Europe
Zsófia Mészner1, Ioana Anca, Francis André
1National Institute of Child Health, Budapest, Hungary. zsmeszner@ogyei.hu
None:
Each year, rotavirus (RV) infection is the leading cause of acute gastroenteritis requiring hospitalisation and of nosocomially transmitted diseases in children younger than 5 years across Central European Vaccination Awareness Group (CEVAG) countries; however, inadequate surveillance systems and lack of routine RV testing still exist in most CEVAG countries, making it difficult to accurately assess the present burden of acute RV gastroenteritis in the younger population. Furthermore, routine immunisation of infants with RV vaccines has not been implemented, and no official and uniform recommendations exist in most of the countries in these territories. The present study provides CEVAG country-specific estimates of the disease burden of RV gastroenteritis among the youngest population and presents evidence-based advice on the use of RV vaccines in the region, while providing a framework for vaccination at the national level.
More Related Videos
Related Concept Videos
Vaccinations
Bacterial Gastroenteritis
Vaccines
Vaccine Production
Arboviral Encephalitis
Cytomegalovirus Disease

